 on development
and dissemination. Mayo Clin Proc 2017;92:423-33.
47. Alonso-Coello P, Schünemann HJ, Moberg J, et al. GRADE Evidence
to Decision (EtD) frameworks: a systematic and transparent
approach to making well informed healthcare choices. 1: introduction. BMJ 2016;353:i2016.
48. Porter JM, Moneta GL. Reporting standards in venous disease: an
update. International consensus committee on chronic venous
disease. J Vasc Surg 1995;21:635-45.
49. Eklof B, Rutherford RB, Bergan JJ, et al. Revision of the CEAP classiﬁcation for chronic venous disorders: consensus statement. J Vasc
Surg 2004;40:1248-52.
50. Lurie F, Passman M, Meisner M, et al. The 2020 update of the CEAP
classiﬁcation system and reporting standards. J Vasc Surg Venous
Lymphat Disord 2020;8:342-52.
51. Eklof B, Perrin M, Delis KT, et al. Updated terminology of chronic
venous disorders: the VEIN-TERM transatlantic interdisciplinary
consensus document. J Vasc Surg 2009;49:498-501.
52. Perrin M, Eklӧf B, Maleti O. The vein glossary. J Vasc Surg Venous
Lymphat Disord 2018;6:e11-217.
53. Paty J, Turner-Bowker DM, Elash CA, Wright D. The VVSymQÒ instrument: use of a new patient-reported outcome measure for
assessment of varicose vein symptoms. Phlebology 2015;31:481-8.
54. Gibson K, Kabnick L; Varithena 013 Investigator G. A multicenter,
randomized, placebo-controlled study to evaluate the efﬁcacy and
safety of Varithena(R